NKRF and lung carcinoma: Similarly, miR-192 downregulates the target gene NKRF to directly activate NF-κB, which contributes to tumorigenesis by inhibiting cell apoptosis, enhancing cell cycle progression, and promoting chemo-resistance in lung cancer [77].